NCT05858749
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Pfizer Headquarters New York, United States
Clinical trial condition
Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
NCT05858749
NCT02231749
NCT03075423
NCT00930033
NCT03967522
NCT04508725
NCT04337970
NCT04802824
NCT03149822
NCT03891485